| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V3632 | Tautomycin | 109946-35-2 | Tautomycin is naturally occurring antifungal antibiotic foundin shellfish and is produced by the bacterium Streptomyces spiroverticillatus. |
|
V3584 | TBK1 PROTAC 1 | 2052306-13-3 | TBK1 PROTAC 1 is a novel, potent and selective TBK1 PROTAC withDC50 of 12nM that selectively degrades TBK1 with excellent selectivityagainst a related kinase IKKε; It is a chemical tool to assess TBK1 as a target in mutant K-Ras cancer cells. |
|
V3887 | Tecovirimat hydrate | 1162664-19-8 | This product is discontinued due to commercial reason |
|
V3708 | Tedizolid phosphate disodium salt | 856867-39-5 | Tedizolid phosphate disodium (DA-7157; TR-700; DA7157; TR700; torezolid; Sivextro) is the disodium salt of Tedizolid phosphate which is the phosphate ester prodrug of tedizolid. |
|
V3655 | Tezosentan | 180384-57-0 | Tezosentan (RO610612; Veletr; RO-610612) is a novel, non-selective and dual antagonist/inhibitor ofendothelian (ETA/ETB) receptor (pA2sof 9.5, 7.7 for ETAand ETB) with the potential to be used for the treatment of congestive heart failure. |
|
V3570 | TL13-12 | 2229037-04-9 | TL13-12 is novel, potent and selective PROTAC degrader of anaplastic lymphoma kinase (ALK) with potential anticancer activity. |
|
V3615 | Tofimilast | 185954-27-2 | Tofimilast (also known as CP-325366) is a novel and potent PDE4 (phosphodiesterase 4) inhibitor. |
|
V4371 | TRASTUZUMAB | Trastuzumab (trade name Herceptin; Anti-Human HER2, Humanized Antibody) is a humanized monoclonal antibody used to treat invasive breast cancer. | |
|
V2469 | Tripeptide-10 Citrulline | 960531-53-7 | Tripeptide-10 citrulline (T10-C) is a biologically active peptide with anti-aging activities and has been reported to be used as an ingredient of cosmetics. |
|
V3940 | Ulevostinag (MK-1454) | 2082743-96-0 | Ulevostinag (MK-1454; MK1454) is an investigational small molecule STING agonist with potential immunomodulatory and anticancer activities. |
|
V3307 | Ulodesine (BCX4208) | 548486-59-5 | Ulodesine (formerly also known as BCX4208) is a novel and potent inhibitor of purine nucleoside phosphorylase (PNP) with the potential to be used for the treatment of psoriasis and gout. |
|
V1894 | UM171 | 1448724-09-1 | UM171 (UM-171) is a potent agonist of human hematopoietic stem cell renewal, independently of AhR suppression. |
|
V4074 | Unifiram (DM 232) | 272786-64-8 | Unifiram (also known as DM-232), a piperazine derived ampakine-like drug, has potent nootropic effects in animal studies with significantly higher potency than piracetam. |
|
V4381 | USTEKINUMAB | 815610-63-0 | Ustekinumab (brand name Stelara; Anti-Human IL-12/IL-23, Human Antibody) is an anti-IL-12/IL-23IgG1κ human monoclonal antibodyused to treat psoriasis. |
|
V4366 | VANIPREVIR | 923590-37-8 | Vaniprevir (formerly known as MK-7009) is a non-covalent competitive inhibitor of the hepatitis C virus (HCV) NS3/4A protease. |
|
V4235 | Vasotide | Vasotide, D(Cys-Leu-Pro-Arg-Cys) [abbreviated as D(CLPRC)], is a novel and potent peptidomimetic compound that targets two retinal VEGF receptors (VEGFR-1 and VEGFR-2) and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. | |
|
V4392 | VATINOXAN HCL | 130466-38-5 | Vatinoxan HCl/hydrochloride (also known as MK-467 hydrochloride and L-659066 hydrochloride) is a novel and potent peripheralα2 adrenergic receptorantagonist. |
|
V2117 | Vedolizumab (Entyvio) | 943609-66-3 | Vedolizumab (trade name Entyvio; Anti-Human lymphocyte α4β7 integrin, Humanized Antibody) is a humanized monoclonal antibody that targets the α4β7integrinfor the treatment of ulcerative colitis and Crohns disease. |
|
V2134 | YKL-05-099 | 1936529-65-5 | YKL-05-099 (YKL05099) is a novel, potent and selective inhibitor of salt-inducible kinase (SIK) with the potential to be used for treatment of inflammatory disorders. |
|
V76337 | 2-Aminoethanethiosulfonic S-Acid | 2937-54-4 |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
